PATRITUMAB

UNII:	86780VJI1Q
Formula:
Preferred Substance Name:	PATRITUMAB

1262787-83-6
AMG888
AMG-888
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEUREGULIN RECEPTOR HER3) (HUMAN MONOCLONAL U3-1287 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL U3-1287 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-447) (HOMO SAPIENS VH (IGHV4-34*01 (99.00%) -(IGHD)-IGHJ2*01) (8.7.11) (1-117) -IGHG1*03 (118-447)), (220-220')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-220') (HOMO SAPIENS V-KAPPA (IGKV4-1*01 (95.00%) -IGKJ1*01) (12.3.9) (1'-113') - IGKC*01 (114'-220')); (226-226'':229-229'')-BISDISULFIDE DIMER
PATRITUMAB [INN]
PATRITUMAB [USAN]
PATRITUMAB [WHO-DD]
U31287
U3-1287
U-31287

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PATRITUMAB

Synonyms and Mappings

Resources